27 Phase III and 8 Phase II Alzheimer’s drugs on the track and likely to be launched in next 5 years
Twenty-seven Alzheimer’s drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according analysis presented at the Alzheimer’s